{"version":"1.0","provider_name":"Brakke\u54a8\u8be2\u7f51\u7ad9","provider_url":"https:\/\/brakkeconsulting.com\/zh","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"347ihXVJ7t\"><a href=\"https:\/\/brakkeconsulting.com\/zh\/23507\/\">2001 \u5e74 10 \u6708 12 \u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u6ce8\u91ca<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/zh\/23507\/embed\/#?secret=347ihXVJ7t\" width=\"600\" height=\"338\" title=\"\u300a2001\u5e7410\u670812\u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u7b80\u8baf\u300b\u2014\u2014\u5e03\u62c9\u514b\u54a8\u8be2\u516c\u53f8\u7f51\u7ad9\" data-secret=\"347ihXVJ7t\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"**************************************************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for October 12, 2001 Copyright &copy; Brakke Consulting, Inc. **************************************************************** Company Earnings Releases &gt;&nbsp; Novartis AG announced that its sales had risen 11 percent in the first nine months of this year from a year ago.&nbsp; The total was $14.53 billion.&nbsp; Animal health sales were down 6% in the period.&nbsp; The US economic slowdown as well as the continued problems due to the foot and mouth disease epidemic in the UK were sited.&nbsp; The farm animal business grew in the Asia Pacific region and in Latin America.&nbsp; Tiamulin sales grew. The companion animal business contended with continued competitive pressure in the flea control segment.&nbsp; Sales of Fortekor, the heart failure treatment for dogs, grew.&nbsp; Capstar was launched in the UK and is expected to add new impetus to sales.&nbsp; (company press release) &gt;&nbsp; Alpharma, Inc. announced it will revise its financial statements for 1999, 2000 and the first two quarters of 2001.&nbsp; The revision will change the timing of recognition of revenue for certain sales of the Company&rsquo;s Animal Health Division.&nbsp; The company estimates that the net effect of these changes will be to increase previously reported sales and operating income in 2001 by approximately $30 million and $17 million, respectively.&nbsp; An aggregate reduction of approximately the same amount of sales andView Full Post;"}